Literature DB >> 20063161

Impact of bloodstream infection on the outcome of children undergoing cardiac surgery.

Raja Abou Elella1, Hani K Najm, Hanan Balkhy, Lily Bullard, Mohamed S Kabbani.   

Abstract

Bloodstream infections (BSIs) are a main cause of nosocomial infection in the critical care area. The development of BSI affects the surgical outcome and increases intensive care unit (ICU) morbidity and mortality. This prospective cohort study was undertaken to determine the incidence, etiology, risk factors, and outcome of BSI for postoperative pediatric cardiac patients in the pediatric cardiac ICU setup. All postoperative pediatric patients admitted to the pediatric cardiac ICU from January 2007 to December 2007 were included in the study. Data were prospectively collected using a standardized data collection form. Patients with BSI (group 1) were compared with non-BSI patients (group 2) in terms of age, weight, surgical complexity score, duration of central line, need to keep the chest open postoperatively, and the length of the pediatric cardiac ICU and hospital stay. Of the 311 patients who underwent cardiac surgery during the study period, 27 (8.6%) were identified as having BSI (group 1). The 311 patients included in the study had a total of 1,043 central line days and a catheter-related BSI incidence density rate of 25.8 per 1,000 central line days. According to univariate analysis, the main risk factors for the development of BSI after pediatric cardiac surgery were lower patient weight (p = 0.005), high surgical complexity score (p < 0.05), open sternum postoperatively (p < 0.05), longer duration of central lines (p < 0.0001), and prolonged pediatric cardiac ICU and hospital stay (p < 0.0001). Gram-negative organisms were responsible for 67% of the BSI in the pediatric cardiac ICU, with pseudomonas (28%) and enterobacter (22%) as the main causative organisms. The mortality rate in the BSI group was 11% compared with 2% in the non-BSI group. In our pediatric cardiac ICU, BSI developed in 8.6% of the children undergoing cardiac surgery, mainly caused by a Gram-negative organism. The main risk factors for BSI in the postoperative pediatric cardiac patient were high surgical complexity, open sternum, low body weight, longer duration of central line, and prolonged pediatric cardiac ICU stay.

Entities:  

Mesh:

Year:  2010        PMID: 20063161     DOI: 10.1007/s00246-009-9624-x

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  19 in total

1.  Risk factors for nosocomial primary bloodstream infection in pediatric intensive care unit patients: a 2-year prospective cohort study.

Authors:  Alexis M Elward; Victoria J Fraser
Journal:  Infect Control Hosp Epidemiol       Date:  2006-05-31       Impact factor: 3.254

2.  National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

Authors: 
Journal:  Am J Infect Control       Date:  2004-12       Impact factor: 2.918

3.  Pediatric cardiac surgery: the effect of hospital and surgeon volume on in-hospital mortality.

Authors:  E L Hannan; M Racz; R E Kavey; J M Quaegebeur; R Williams
Journal:  Pediatrics       Date:  1998-06       Impact factor: 7.124

4.  Pro-inflammatory cytokines after different kinds of cardio-thoracic surgical procedures: is what we see what we know?

Authors:  Axel Franke; Wolfgang Lante; Volker Fackeldey; Horst P Becker; Edmond Kurig; Lothar G Zöller; Christian Weinhold; Andreas Markewitz
Journal:  Eur J Cardiothorac Surg       Date:  2005-10       Impact factor: 4.191

5.  Nosocomial infections after cardiac surgery in infants and children: incidence and risk factors.

Authors:  I Levy; B Ovadia; E Erez; S Rinat; S Ashkenazi; E Birk; H Konisberger; B Vidne; O Dagan
Journal:  J Hosp Infect       Date:  2003-02       Impact factor: 3.926

6.  Transthoracic intracardiac catheters in pediatric patients recovering from congenital heart defect surgery: associated complications and outcomes.

Authors:  H R Flori; L D Johnson; F L Hanley; J R Fineman
Journal:  Crit Care Med       Date:  2000-08       Impact factor: 7.598

7.  Rate, risk factors, and outcomes of nosocomial primary bloodstream infection in pediatric intensive care unit patients.

Authors:  Jeya S Yogaraj; Alexis M Elward; Victoria J Fraser
Journal:  Pediatrics       Date:  2002-09       Impact factor: 7.124

8.  Nosocomial infections in the pediatric intensive care units in Lithuania.

Authors:  Jolanta Asembergiene; Vaidotas Gurskis; Rimantas Kevalas; Rolanda Valinteliene
Journal:  Medicina (Kaunas)       Date:  2009       Impact factor: 2.430

9.  Nosocomial pneumonia in a pediatric intensive care unit.

Authors:  P K Patra; M Jayashree; S Singhi; P Ray; A K Saxena
Journal:  Indian Pediatr       Date:  2007-07       Impact factor: 1.411

10.  Nosocomial catheter-related bloodstream infections in a pediatric intensive care unit: risk and rates associated with various intravascular technologies.

Authors:  Folafoluwa O Odetola; Frank W Moler; Ronald E Dechert; Kristen VanDerElzen; Carol Chenoweth
Journal:  Pediatr Crit Care Med       Date:  2003-10       Impact factor: 3.624

View more
  26 in total

Review 1.  Healthcare-associated infection prevention in pediatric intensive care units: a review.

Authors:  N Joram; L de Saint Blanquat; D Stamm; E Launay; C Gras-Le Guen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-01       Impact factor: 3.267

2.  Heterotaxy syndrome: defining contemporary disease trends.

Authors:  Terence W Prendiville; Leslie L Barton; William R Thompson; Doran L Fink; Kathryn W Holmes
Journal:  Pediatr Cardiol       Date:  2010-08-21       Impact factor: 1.655

3.  The Epidemiology of Healthcare-associated Infections in Pediatric Cardiac Intensive Care Units.

Authors:  Jeffrey A Alten; A K M Fazlur Rahman; Hayden J Zaccagni; Andrew Shin; David S Cooper; Joshua J Blinder; Lauren Retzloff; Inmaculada B Aban; Eric M Graham; Jeffrey Zampi; Yuliya Domnina; Michael G Gaies
Journal:  Pediatr Infect Dis J       Date:  2018-08       Impact factor: 2.129

4.  Sepsis in young infants with congenital heart disease.

Authors:  S B Ascher; P B Smith; R H Clark; M Cohen-Wolkowiez; J S Li; K Watt; E Jacqz-Aigrain; F Kaguelidou; P Manzoni; D K Benjamin
Journal:  Early Hum Dev       Date:  2012-05       Impact factor: 2.079

5.  Sepsis in the pediatric cardiac intensive care unit.

Authors:  Derek S Wheeler; Howard E Jeffries; Jerry J Zimmerman; Hector R Wong; Joseph A Carcillo
Journal:  World J Pediatr Congenit Heart Surg       Date:  2011-07-01

6.  Cell Saver Blood Reinfusion Up to 24 Hours Post Collection in Pediatric Cardiac Surgical Patients Does Not Increase Incidence of Hospital-Acquired Infections or Mortality.

Authors:  Laura Boulos; Joseph D Kuebler; Ron Angona; Dawn Sweeney; Hongyue Wang; Elizabeth Nocera; Jill M Cholette
Journal:  J Extra Corpor Technol       Date:  2021-09

7.  Health care-associated infections in children after cardiac surgery.

Authors:  Rebecca F Turcotte; Ava Brozovich; Rozelle Corda; Ryan T Demmer; Katherine V Biagas; Diane Mangino; Lisa Covington; Anne Ferris; Brian Thumm; Emile Bacha; Art Smerling; Lisa Saiman
Journal:  Pediatr Cardiol       Date:  2014-07-05       Impact factor: 1.655

Review 8.  Sepsis in Pediatric Cardiac Intensive Care.

Authors:  Derek S Wheeler; Hector R Wong
Journal:  Pediatr Crit Care Med       Date:  2016-08       Impact factor: 3.624

9.  Risk-adjusted monitoring of blood-stream infection in paediatric intensive care: a data linkage study.

Authors:  Katie Harron; Angie Wade; Berit Muller-Pebody; Harvey Goldstein; Roger Parslow; Jim Gray; John C Hartley; Quen Mok; Ruth Gilbert
Journal:  Intensive Care Med       Date:  2013-02-12       Impact factor: 17.440

10.  Children with Chronic Disease Bear the Highest Burden of Pediatric Sepsis.

Authors:  Andrew J Prout; Victor B Talisa; Joseph A Carcillo; Florian B Mayr; Derek C Angus; Christopher W Seymour; Chung-Chou H Chang; Sachin Yende
Journal:  J Pediatr       Date:  2018-05-09       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.